Longevity & AgingHDAC7 Emerges as a New Target Against Alzheimer's Tau Tangles
Tau protein tangles are a hallmark of Alzheimer's disease and a prime example of how failing protein quality control damages the aging brain. Researchers now report that an enzyme called HDAC7 acts as a molecular bridge, bringing the kinase GSK3β together with hyperphosphorylated tau (hTau) inside neurons. Because GSK3β is known to drive the excessive phosphate tagging that makes tau misfold and clump, this bridging role may help push neurons toward disease. In mice engineered to carry hTau, removing HDAC7 improved cognitive decline. The finding points to HDAC7 as a possible new drug target, offering a different angle than approaches that go after tau or GSK3β directly. The work is preclinical, so it is an early lead rather than a treatment. Still, it deepens our understanding of how proteostasis loss contributes to age-related neurodegeneration and where it might be interrupted.